01 1Aurobindo Pharma Limited
01 1SUMATRIPTAN SUCCINATE USP (PROCESS II)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-01-10
Pay. Date : 2017-11-14
DMF Number : 32218
Submission : 2017-11-15
Status : Active
Type : II
20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SUMATRIPTAN SUCCINATE USP (PROCESS II), with a corresponding US DMF Number 32218.
Remarkably, this DMF maintains an Active status since its submission on November 15, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 10, 2018, and payment made on November 14, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
